# 21 CFR 50.23 Exception from general requirements.

21 CFR 50.23 Exception from general requirements., “Exception from general requirements”, is a CFR section of [21 CFR Part 50, Subpart B—Informed Consent of Human Subjects](https://ontology.bommaritollc.com/id/01a0f094-b4bd-70df-84ce-c25da8001fb6); in force.

IRI: <https://ontology.bommaritollc.com/id/01a0f094-bbda-720c-8ead-cee1a89f8a5b>

Within: [Title 21—Food and Drugs](https://ontology.bommaritollc.com/id/01a0f094-b437-7426-9a1d-f0a9f3d3e1aa) › [21 CFR Chapter I—FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES](https://ontology.bommaritollc.com/id/01a0f094-b455-74b7-9458-ed95d7b5ea58) › [21 CFR Chapter I, Subchapter A—GENERAL](https://ontology.bommaritollc.com/id/01a0f094-b456-7008-a83b-fa94ddeea764) › [21 CFR Part 50—Protection of human subjects](https://ontology.bommaritollc.com/id/01a0f094-b7f0-7092-8cfc-6d60da0417f5) › [21 CFR Part 50, Subpart B—Informed Consent of Human Subjects](https://ontology.bommaritollc.com/id/01a0f094-b4bd-70df-84ce-c25da8001fb6)

Type: [schema:Legislation](https://schema.org/Legislation)

- `adms:identifier`: [cfr-section 21 CFR 50.23](https://ontology.bommaritollc.com/id/01a0f094-bbdb-7063-9b3b-003dae121fa8)
- `eli:cites`:
  - [10 U.S.C. 1107 Notice of use of an investigational new drug or a drug unapproved for its applied use](https://ontology.bommaritollc.com/id/01a0f064-9d05-7202-b88a-ec45a8b2d634)
  - [21 U.S.C. 355 New drugs](https://ontology.bommaritollc.com/id/01a0f06c-ccd6-7038-b7ea-5f9e1b3b3f50)
  - [21 CFR Part 50—Protection of human subjects](https://ontology.bommaritollc.com/id/01a0f094-b7f0-7092-8cfc-6d60da0417f5)
  - [21 CFR Part 312—Investigational new drug application](https://ontology.bommaritollc.com/id/01a0f094-b84c-75c3-a0c0-d388d85f1044)
  - [21 CFR 50.25 Elements of informed consent.](https://ontology.bommaritollc.com/id/01a0f094-bbdc-7435-92db-8cfd35e62cc3)
  - [21 CFR 56.115 IRB records.](https://ontology.bommaritollc.com/id/01a0f094-bc1c-7655-a013-5ddfd5f3deaa)
- `prov:wasDerivedFrom`:
  - [evidence from https://www.govinfo.gov/app/details/CFR-2025-title21-vol1](https://ontology.bommaritollc.com/id/01a0f094-bbda-720c-8ead-cee054eeec3d)
  - [evidence from https://www.govinfo.gov/app/details/](https://ontology.bommaritollc.com/id/01a0f094-e111-752a-a409-66022e47d7cf)
  - [evidence from https://www.govinfo.gov/app/details/](https://ontology.bommaritollc.com/id/01a0f0d0-bfa2-7490-a1c3-51235e8a5b50)
  - [evidence from https://www.govinfo.gov/link/cfr/21/50?sectionnum=23&year=mostrecent&link-type=details](https://ontology.bommaritollc.com/id/01a10f17-6333-71ad-b7e5-ff4c6c3d7d07)
- `schema:isPartOf`: [21 CFR Part 50, Subpart B—Informed Consent of Human Subjects](https://ontology.bommaritollc.com/id/01a0f094-b4bd-70df-84ce-c25da8001fb6)
- `schema:legislationIdentifier`: 21 CFR 50.23
- `schema:legislationJurisdiction`: [United States](https://ontology.bommaritollc.com/id/01a0ed8e-f797-7004-b7f5-bec2695977c0)
- `schema:legislationLegalForce`: [schema:InForce](https://schema.org/InForce)
- `schema:legislationType`: [CFR section](https://ontology.bommaritollc.com/vocab/leg/cfrSection)
- `schema:name`: Exception from general requirements
- `schema:url`: [https://www.govinfo.gov/link/cfr/21/50?sectionnum=23&year=mostrecent&link-type=details](https://www.govinfo.gov/link/cfr/21/50?sectionnum=23&year=mostrecent&link-type=details)
- `skos:prefLabel`: 21 CFR 50.23 Exception from general requirements.

## Elsewhere

- [Official page](https://www.govinfo.gov/link/cfr/21/50?sectionnum=23&year=mostrecent&link-type=details) (www.govinfo.gov)
- [Source](https://www.govinfo.gov/app/details/CFR-2025-title21-vol1) (www.govinfo.gov)
- [Source](https://www.govinfo.gov/app/details/) (www.govinfo.gov)

## Pointing here

- Cited by (4; `eli:cites`):
  - [21 CFR 312.120 Foreign clinical studies not conducted under an IND.](https://ontology.bommaritollc.com/id/01a0f094-c4b2-76f2-9c7d-bef6032144ab)
  - [21 CFR 312.42 Clinical holds and requests for modification.](https://ontology.bommaritollc.com/id/01a0f094-c49a-73d0-9ff1-98da03c4f11e)
  - [21 CFR 50.20 General requirements for informed consent.](https://ontology.bommaritollc.com/id/01a0f094-bbd9-7754-a38d-e02dd93201ee)
  - [21 CFR 812.28 Acceptance of data from clinical investigations conducted outside the United States.](https://ontology.bommaritollc.com/id/01a0f094-cc8d-734c-b07f-77e160d8e2c1)

---
Also as: [Turtle](https://ontology.bommaritollc.com/id/01a0f094-bbda-720c-8ead-cee1a89f8a5b.ttl), [JSON-LD](https://ontology.bommaritollc.com/id/01a0f094-bbda-720c-8ead-cee1a89f8a5b.jsonld), [N-Triples](https://ontology.bommaritollc.com/id/01a0f094-bbda-720c-8ead-cee1a89f8a5b.nt), [HTML](https://ontology.bommaritollc.com/id/01a0f094-bbda-720c-8ead-cee1a89f8a5b)
Cite as: 21 CFR 50.23 Exception from general requirements.. bc-ontology, release 0.1.0-rc38, 2026-10-21. https://ontology.bommaritollc.com/id/01a0f094-bbda-720c-8ead-cee1a89f8a5b
Release 0.1.0-rc38, graph hash 05350a11cf9d0c42fba51e92b877115781ab65cb92afcd6b172ff9f8f4abf0bd.
